Tyra Biosciences to Participate at Upcoming Investor Conferences
Provided By PR Newswire
Last update: May 12, 2025
CARLSBAD, Calif., May 12, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced that management will participate in the following investor conferences:
Read more at prnewswire.com
